Scholars Central

Editorial Board Member

Dr Gerhard Carl Hildebrandt

Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, USA

About

As published by the journal they serve.

Dr. Gerhard Carl Hildebrandt is currently the Medical Director of the Blood and Marrow Transplant Program at the University of Utah School of Medicine and a Huntsman Cancer Institute Investigator. His clinical interest are the treatment of hematologic malignancies and autologous and allogeneic hematopoietic cell transplantation. His research focuses on the development of graft versus host disease and acute and chronic lung injury in allogeneic transplant recipients, aiming to bring results from the bench to the bedside. He is member of ASH, ASBMT, ASCO, AACR and others, and serves as reviewer on numerous peer-reviewed journals. He obtained is medical degree from the Johannes Gutenberg University of Mainz, Germany, and did his postgraduate training in Internal Medicine and in Hematology and Oncology at the University of Regensburg, Germany. Prior, he was Director of the Blood and Marrow Transplant Program at Louisiana State University Health Sciences Center – Shreveport, Louisiana.

Research interests

  • Dr. Gerhard Carl Hildebrandt research interests includes Allogeneic hematopoietic cell transplantation – acute and chronic graft versus host disease – acute and chronic lung injury.

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels